These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1212563

  • 1. Postnatal development of dopamine deamination in the striatum of the rat.
    Davis AJ, Holzbauer M, Sharman DF.
    Br J Pharmacol; 1975 Dec; 55(4):558-60. PubMed ID: 1212563
    [Abstract] [Full Text] [Related]

  • 2. Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.
    Waldmeier PC, Delini-Stula A, Maître L.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 292(1):9-14. PubMed ID: 934359
    [Abstract] [Full Text] [Related]

  • 3. Proceedings: Lack of significance of MAO-B for in vivo deamination of dopamine.
    Waldmeier PC, Maître L.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Dec; 287 Suppl():R2. PubMed ID: 1143400
    [No Abstract] [Full Text] [Related]

  • 4. Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.
    Colzi A, d'Agostini F, Kettler R, Borroni E, Da Prada M.
    J Neural Transm Suppl; 1990 Dec; 32():79-84. PubMed ID: 2089114
    [Abstract] [Full Text] [Related]

  • 5. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
    Garrett MC, Soares-da-Silva P.
    Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
    [Abstract] [Full Text] [Related]

  • 6. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.
    Waldmeier PC, Maître L.
    Psychopharmacology (Berl); 1977 Apr 29; 52(2):137-44. PubMed ID: 407597
    [No Abstract] [Full Text] [Related]

  • 7. Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
    Gramsch C, Bläsig J, Herz A.
    Eur J Pharmacol; 1977 Aug 01; 44(3):231-40. PubMed ID: 560969
    [Abstract] [Full Text] [Related]

  • 8. On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum.
    Awazi N, Guldberg HC.
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May 01; 303(1):63-72. PubMed ID: 307696
    [No Abstract] [Full Text] [Related]

  • 9. Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.
    Kwok RP, Juorio AV.
    Neuroendocrinology; 1986 May 01; 43(5):590-6. PubMed ID: 3528901
    [Abstract] [Full Text] [Related]

  • 10. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P.
    J Pharm Pharmacol; 1987 Feb 01; 39(2):127-9. PubMed ID: 2881997
    [Abstract] [Full Text] [Related]

  • 11. Ontogenesis of enzyme systems deaminating different monoamines.
    Blatchford D, Holzbauer M.
    Br J Pharmacol; 1976 Jun 01; 57(2):279-93. PubMed ID: 938797
    [Abstract] [Full Text] [Related]

  • 12. Age-related changes in the metabolism of neurotransmitters in rat striatum: a microdialysis study.
    Nakano M, Mizuno T.
    Mech Ageing Dev; 1996 Feb 24; 86(2):95-104. PubMed ID: 8852930
    [Abstract] [Full Text] [Related]

  • 13. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N, Barneoud P, Carter C, Caille D, Sontag N, Marc C, Lolivier J, Gardes A, Perron C, Le Kim A, Charieras T, Pandini M, Burnier P, Puech F, Jegham S, George P, Scatton B, Curet O.
    J Pharmacol Exp Ther; 2004 Sep 24; 310(3):1171-82. PubMed ID: 15178694
    [Abstract] [Full Text] [Related]

  • 14. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug 24; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 15. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L, Deng M, Zhang S, Fang Y, Li L.
    Clin Exp Pharmacol Physiol; 2014 Sep 24; 41(9):685-90. PubMed ID: 24910244
    [Abstract] [Full Text] [Related]

  • 16. Acute pancreatitis affects the metabolism of catecholamine neurotransmitters in rats.
    Jiang H, Li F, Liu S, Sun H, Cui Y, Wu Y.
    Neuroscience; 2014 May 30; 268():112-7. PubMed ID: 24657461
    [Abstract] [Full Text] [Related]

  • 17. The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine.
    Berry MD, Scarr E, Zhu MY, Paterson IA, Juorio AV.
    Br J Pharmacol; 1994 Dec 30; 113(4):1159-66. PubMed ID: 7889269
    [Abstract] [Full Text] [Related]

  • 18. Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey.
    Finberg JP, Wang J, Bankiewicz K, Harvey-White J, Kopin IJ, Goldstein DS.
    J Neural Transm Suppl; 1998 Dec 30; 52():279-85. PubMed ID: 9564628
    [Abstract] [Full Text] [Related]

  • 19. Determination of homovanillic acid turnover in rat striatum using a monoamine oxidase inhibitor.
    Wiesel FA, Fri CG, Sedvall G.
    Eur J Pharmacol; 1973 Jul 30; 23(1):104-6. PubMed ID: 4733765
    [No Abstract] [Full Text] [Related]

  • 20. Participation of type A monoamine oxidase in the activated deamination of brain monoamines shortly after reperfusion in rats.
    Kumagae Y, Matsui Y, Iwata N.
    Jpn J Pharmacol; 1990 Dec 30; 54(4):407-13. PubMed ID: 2087001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.